The gene for the coagulation protein factor Vil contains several common restriction fragment length polymorphisms which can be used to analyse the pattern of inheritance offactor VIII alleles within families. This can be exploited to identify carriers of haemophilia, an X-linked inherited disorder characterised by deficiency of factor VIIL. In this study the polymerase chain reaction was used to analyse a polymorphism recognisd by the restriction enzyme Bcll, located at intron 18 of the factor VIII gene. The restriction fragment patterns generated were used to track the inheritance of mutated factor VIII alleles within families allowing haemophilia carrier status to be determined in individuals at risk.
INTRODUCTION
Haemophilia is an X-linked inherited disorder which affects one male in 10,000. The condition is characterised by abnormal bleeding due to the deficiency of factor VIII, a protein necessary for normal coagulation. The deficiency is caused by heritable mutations within the factor Vill gene. Male off -spring of female carriers have a 50 % chance of manifesting the condition. Female off-spring have a 50% chance of being carriers. Determination of haemophilia carrier status facilitates counselling of individuals at risk of having an affected child, allowing them to make informed choices regarding parenthood. Initial attempts to identify carriers were based on measurements of the factor Vill coagulant activity in the plasma.' This approach proved unreliable due to the physiological variability in factor Vill levels and the random nature of X chromosome inactivaction in females. 2 The advent of recombinant DNA technology has permitted unequivocal identification of carriers in about two -thirds of cases using restriction fragment length polymorphisms (RFLPs).3 These are naturally occurring variations in DNA sequence which alter the pattern of fragments produced when DNA corresponding to a particular gene is treated with a restriction endonuclease. The variations can be exploited to distinguish not only between genes carried by different individuals, but also between homologous pairs of genes (alleles) within individuals. Three common RFLPs occur in the factor VIII gene located at introns 18, 22, and 26. They are recognised by the The Ulster Medical Journal restriction enzymes, Bcll,4 Xbal 5 and Bgl1.6 By analysing the restriction fragment pattern of the factor VIII gene in DNA from a haemophilic patient using these enzymes, it is possible to identify the RFLP pattern associated with the X chromosome carrying the mutated gene. By comparing the pattern with that generated by the mother and sisters of the haemophilic, it is possible to trace the inheritance pattern of the mutated gene within the family and so to establish carrier members. Restriction fragment length polymorphisms can be analysed using the polymerase chain reaction.7 The technique allows an individual gene, contained within a complex mixture of genes such as chromosomal DNA, to be copied exclusively in a simple enzyme catalysed reaction until its DNA becomes the dominant species in the reaction mixture and enough is obtained to allow detailed analysis of that gene. Individual genes can be amplified about one million fold, and up to 1pg of specific DNA can be obtained. This paper describes how the polymerase chain reaction was used to amplify the part of the factor Vill gene containing a RFLP recognised by the enzyme Bcll, and how analysis of the restriction fragment pattern of the amplified DNA with Bcll was used to identify carriers of haemophilia. Since the maternal allele in this case is associated with haemophilia, she must be classified as a carrier.
MATERIALS AND METHODS

DISCUSSION
The use of restriction fragment length polymorphisms to identify carriers of haemophilia represents an improvement on previous methods based on measurements of factor Vill plasma clotting activity.3 Because the restriction fragment length polymorphism used is intragenic, it was possible to track the inheritance pattern of the X chromosome carrying the mutated gene within the pedigree with complete certainty. The results of carrier testing by this method should therefore be considered unequivocal. This contrasts with methods based on phenotypic data which give only a probability of carriership and have a finite error rate. 
